Why Choose us

Speed & Quality

Divergene has developed a robust framework for quickly creating, testing, and implementing new NGS analysis workflow utilizing both open-source and proprietary, custom-built tools.

Experienced Team

We are a team of Ph.D. bioinformaticians with expertise in vector discovery/engineering and vector QC to create best-in-class, tailor-made NGS solutions for you.

Competitive Pricing

We utilize subscription-based software as a service (SaaS) model to deliver NGS analysis pipelines as a service, freeing you from complex software and building an in-house team.

NGS Platform Agnostic

Divergene’s unique combination of deep domain expertise in gene therapy, editing, and sequencing enables powerful iterative design for the platform agnostic tools needed.

Democratizing data-driven gene therapy, together.

Divergene’s mission is to build the future of AI-assisted gene therapy and editing. We are integrating multimodal data, unlocking the existing data silos, and developing machine learning models to produce actionable insights that could eventually support gene therapy professionals to improve patient outcomes.

Retain ownership of your data

Divergene’s platform provides a safe, secure, and instantly accessible environment to standardize, compute, and analyze NGS data, generating insights from complex sequencing data sets that have the potential to improve gene therapy and editing. We give organizations the ability to quickly and thoroughly analyze their data. Our customers perform sequencing on their own samples, retain custody of both their samples and data, and use the Divergene’s platform to analyze data and gain actionable insights. Our intention is to establish a technology company that would greatly enhance patient outcome.

Our vision

Divergene believes that molecular biology, data science, and computer science nexus is where the most fascinating developments are happening. With the ultimate objective of allowing breakthrough therapy and enhancing human health. Divergene is actively working to create the technologies necessary to make this vision a reality. At Divergene, we’ve worked hard to foster a strong entrepreneurial spirit, inspiring each individual to make a difference. Our company DNA is the secret to our success and a promise of hope for millions of people since it is based on quality, accuracy, and resilience.

Our Services

Divergene works closely with CDMOs and gene therapy companies to support their next-generation sequencing capability from upstream vector engineering to downstream vector QC analyzing genome heterogeneity and integrity etc. We create best-in-class, custom-made NGS analysis workflow that best suits their needs.

NGS Analysis Development

Our customers perform NGS testing on their own samples using their in-house sequencing platforms. Divergene will process and analyze the raw NGS data files and create interactive actionable dashboard/report.

End-to-end Sequencing

From nucleotide to interactive dashboard/report all inclusive services. Divergene will handle the library prep, QC, sequencing and analysis utilizing illumina, PacBio, or Nanopore sequencing platform depending on needs.

WHO WE ARE

Facts about Divergene
99 %
Positive feedback from customers and partners
< 60 days
To build, test and deploy new NGS analysis pipeline
> 8 x
More affordable than hiring an in-house team
> 10 x
Better customer service and response rate

Our Team

Kam To, PhD, MBA, MS
Co-Founder
Paola Correa, PhD
Co-Founder
Alexander Ross, MBA
Chief Operating and Finance Officer
Jennifer Campbell
Vice President, Strategic Marketing and Sales Operations

Get in touch

WE ARE ACCEPTING NEW CHALLENGES!

Enhance your NGS data 10X with Divergene’s powerful bioinformatics platform, and scale your genomic projects. We would be happy to answer your questions or discuss your projects.



Contact

800 Park Offices Dr, Morrisville, NC 27560
support@divergene.com